Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.59 |
| ▸ | ESR1 | P03372 | 3/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | CTRC | Q99895 | 1/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31458516 | 1.00 | CYP1A2 (0.71) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL31470616 | 0.93 | CYP2A6 (0.62) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL21203436 | 0.93 | CYP1A2 (0.68) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL24377389 | 0.93 | CYP2A6 (0.62) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL24377050 | 0.93 | CYP2A6 (0.62) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL21906405 | 0.91 | CYP2A6 (0.65) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL31690684 | 0.91 | CYP2A6 (0.65) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL30622737 | 0.91 | CYP2A6 (0.65) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL11467510 | 0.91 | CYP2A6 (0.65) | CYP1A2ESR2ESR1CYP2A6KDM4E | |
| SCHEMBL30659437 | 0.91 | CYP2A6 (0.65) | CYP1A2ESR2ESR1CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260047338-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4596528-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024071332-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 保土谷化学工業株式会社 | 2024-04-04 | — | — | WO | disclosed |
| EP-3518303-B1 | N-(4-(8-(PHENYL)NAPHTHALEN-2-YL)PHENYL)-N,N'-DI(PHENYL)-AMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2021-10-06 | — | — | EP | disclosed |
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
| US-20190237668-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-01 | — | — | US | disclosed |
| EP-3518303-A1 | N-(4-(8-(PHENYL)NAPHTHALEN-2-YL)PHENYL)-N,N'-DI(PHENYL)-AMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES | Samsung Display Co., Ltd. (KR) | 2019-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237668-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC18A2, SLC18A1, MAOA | CYP1A2 236/4885ESR2 1070/4885ESR1 537/4885 |
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC18A2, SLC18A1, MAOA | CYP1A2 236/4885ESR2 1070/4885ESR1 537/4885 |
| US-20260047338-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | HCN1, HCN2, HVCN1 | CYP1A2 486/4885ESR2 180/4885ESR1 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.